Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

RepliCel Life Sciences Inc (OTCQB:REPCF)

0.5984
Delayed Data
As of Mar 24
 -0.0246 / -3.96%
Today’s Change
0.43
Today|||52-Week Range
1.50
-15.73%
Year-to-Date
SECTOR
Non-Energy Minerals
INDUSTRY
Precious Metals
MARKET CAP
$11.0M

Company Description

RepliCel Life Sciences, Inc. is regenerative medicine company. It focuses on developing autologous cell therapies that address conditions linked to a deficit of healthy cells required for normal healing and function. The diseases currently being addressed are chronic tendinosis, skin aging and androgenetic alopecia. RepliCel Life Sciences was founded on April 24, 1967 and is headquartered in Vancouver, Canada.

Contact Information

RepliCel Life Sciences, Inc.
401 West Georgia Street
Vancouver British Columbia V6B 5A1
P:(604) 248-8730
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Robert Lee BucklerPresident, Chief Executive Officer & Director
Thomas Albert KordybackChief Financial Officer
Darrell PanichVice President-Clinical Affairs
Rolf HoffmannChief Medical Officer
Kevin McElweeChief Scientific Officer